The Swiss Registry for Heart Diseases in Children Living in Switzerland. SPHC

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

590 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-06-01

Study Completion Date

2023-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Swiss Pediatric Heart Cohort aims to collect representative longitudinal data on all children diagnosed with a clinically relevant heart disease in Switzerland. The long-term goal is to optimize diagnosis and therapy, and to allow setting up national research projects.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures

NCT04604418

Congenital Heart Disease in Children

RECRUITING

Complications in Pediatric Mechanical Circulatory Assistance: Evaluation of Infection Management.

NCT05983341

Heart Failure Implant Infection

UNKNOWN

Resuscitation Registry in CHD

NCT05373498

Cardiac Arrest Congenital Heart Disease

RECRUITING

Bedside Evaluation of Coagulation in Children With Congenital Heart Disease

NCT02387944

Congenital Heart Defect Blood Coagulation Disorder

COMPLETED

Long-term Survival After Single-ventricle Palliation

NCT03356574

Heart Defects, Congenital

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the entire spectrum of childhood diseases, heart disease occupy a special position regarding incidence; Congenital heart defects are among the most common organ abnormalities, moderate and severe forms of congenital heart diseases occur with a frequency of about 6 to 8 per 1000 live births. Rapid advances in diagnostic and therapeutic options in recent decades have led to a spectacular improvement in prognosis.

So far, data from heart diseases in children in Switzerland are not recorded centrally. A national registry collecting all relevant personal and medical data, as in other European countries, e.g. Finland, Sweden or Germany does not exist. The incidence and course of heart diseases in children in Switzerland are therefore unknown and can only be extrapolated indirectly from other countries. The SPHC project was therefore initiated by the Swiss pediatric cardiologists and is supported by its professional association, the Swiss Society for Pediatric Cardiology (Schweizerische Gesellschaft für pädiatrische Kardiologie; SGPK), as well as by its research association, the Association for Pediatric Heart Research Switzerland (Verein Kinderherzforschung Schweiz; VKHFS).

The aim of medical efforts in children with heart disease has shifted in recent years from a mere assurance of survival to an overall optimization of morbidity. These patients are expected to have a good perspective with normal growth, development, and quality of life well into adulthood. This goal can be achieved by researching the incidence and disease progression as well as the diagnostic and therapeutic measures in Switzerland. In this way, conclusions can be drawn, which lead to a modification of the therapeutic procedures and finally improve the prognosis of heart disease. The statistical significance of individual case descriptions or retrospective case series of individual centers, as practiced today, is insufficient for these purposes.

The aim of the SPHC is to optimize the diagnosis and therapy of all children with heart disease in Switzerland. In particular, the following goals are pursued:

* Describe incidence of heart diseases in childhood
* Enable research on the cause of the disease
* Record long-term history of mortality, morbidity and quality of life
* Describe therapeutic measures (medications, cardiac catheterization, cardiac surgery) regarding efficacy and safety
* Identify risk factors for a good / bad prognosis
* Promote prevention
* Collect basic data for the planning of care and for health economic analyses in the context of public health research projects
* Provide data for international collaborative studies
* A collaboration with Registry of adults with congenital heart defects (Grown Up Congenital Heart Disease, GUCH) is anticipated. This registry also uses SecuTrial® and is also located in the Clinical Trial Centre (CTC) of the University Zürich.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Disease Congenital

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with heart diseases and
* age at diagnosis between 0 and 18 years and
* resident and / or treated in Switzerland and
* signed informed consent